155 related articles for article (PubMed ID: 25339018)
21. 5,10-Methylenetetrahydrofolate reductase polymorphisms and colon cancer risk: a meta-analysis.
Fang XY; Xu WD; Huang Q; Yang XK; Liu YY; Leng RX; Pan HF; Ye DQ
Asian Pac J Cancer Prev; 2014; 15(19):8245-50. PubMed ID: 25339013
[TBL] [Abstract][Full Text] [Related]
22. The Relationship of the TLR9 and TLR2 Genetic Polymorphisms with Cervical Cancer Risk: a Meta-Analysis of Case-Control Studies.
Yang S; Liu L; Xu D; Li X
Pathol Oncol Res; 2020 Jan; 26(1):307-315. PubMed ID: 30215163
[TBL] [Abstract][Full Text] [Related]
23. The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: a meta-analysis.
Wang B; Zhu JM; Fan YG; Feng CC; Chen GM; Chen H; Pan HF; Ye DQ
Gene; 2013 Sep; 527(1):95-101. PubMed ID: 23747396
[TBL] [Abstract][Full Text] [Related]
24. Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: a meta-analysis involving 16,703 individuals.
Wang K; Liu L; Zhu ZM; Shao JH; Xin L
Cytokine; 2011 Nov; 56(2):167-73. PubMed ID: 21798757
[TBL] [Abstract][Full Text] [Related]
25. The association between polymorphisms in the PDCD1 gene and the risk of cancer: A PRISMA-compliant meta-analysis.
Zhang J; Zhao T; Xu C; Huang J; Yu H
Medicine (Baltimore); 2016 Oct; 95(40):e4423. PubMed ID: 27749524
[TBL] [Abstract][Full Text] [Related]
26. Associations between PTPN22 and TLR9 polymorphisms and systemic lupus erythematosus: a comprehensive meta-analysis.
Hu LY; Cheng Z; Zhang B; Yin Q; Zhu XW; Zhao PP; Han MY; Wang XB; Zheng HF
Arch Dermatol Res; 2017 Aug; 309(6):461-477. PubMed ID: 28528372
[TBL] [Abstract][Full Text] [Related]
27. HIF-1α 1772 C/T and 1790 G/A polymorphisms are significantly associated with higher cancer risk: an updated meta-analysis from 34 case-control studies.
Yang X; Zhu HC; Zhang C; Qin Q; Liu J; Xu LP; Zhao LJ; Zhang Q; Cai J; Ma JX; Cheng HY; Sun XC
PLoS One; 2013; 8(11):e80396. PubMed ID: 24260383
[TBL] [Abstract][Full Text] [Related]
28. The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis.
Yang M; Zou Y; Bai Y; Li M
J Orthop Sci; 2015 Jan; 20(1):55-63. PubMed ID: 25270018
[TBL] [Abstract][Full Text] [Related]
29. Involvement of Toll-like Receptor 9 polymorphism in cervical cancer development.
Roszak A; Lianeri M; Sowińska A; Jagodziński PP
Mol Biol Rep; 2012 Aug; 39(8):8425-30. PubMed ID: 22714906
[TBL] [Abstract][Full Text] [Related]
30. TLR9 Rs352140 polymorphism contributes to a decreased risk of bacterial meningitis: evidence from a meta-analysis.
Xue H; Peng H; Li J; Li M; Lu S
Epidemiol Infect; 2020 Nov; 148():e294. PubMed ID: 33143777
[TBL] [Abstract][Full Text] [Related]
31. The Associations between Toll-Like Receptor 9 Gene Polymorphisms and Cervical Cancer Susceptibility.
Tian S; Zhang L; Yang T; Wei X; Zhang L; Yu Y; Li Y; Cao D; Yang X
Mediators Inflamm; 2018; 2018():9127146. PubMed ID: 30147445
[TBL] [Abstract][Full Text] [Related]
32. TLR9 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.
Wang X; Xue L; Yang Y; Xu L; Zhang G
PLoS One; 2013; 8(6):e65731. PubMed ID: 23776537
[TBL] [Abstract][Full Text] [Related]
33. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
Yi K; Yang L; Lan Z; Xi M
Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
[TBL] [Abstract][Full Text] [Related]
34. The G894t, T-786c and 4b/a polymorphisms in Enos gene and cancer risk: a meta-analysis.
Zhang L; Chen LM; Wang MN; Chen XJ; Li N; Huang YD; Chen M
J Evid Based Med; 2014 Dec; 7(4):263-9. PubMed ID: 25586457
[TBL] [Abstract][Full Text] [Related]
35. TLR9 gene polymorphism -1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population.
Martínez-Campos C; Bahena-Román M; Torres-Poveda K; Burguete-García AI; Madrid-Marina V
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2437-2445. PubMed ID: 28819773
[TBL] [Abstract][Full Text] [Related]
36. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis.
Zhu CL; Huang Q; Liu CH; Lin XS; Xie F; Shao F
Asian Pac J Cancer Prev; 2013; 14(4):2349-54. PubMed ID: 23725139
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-2 -1306 C>T gene polymorphism is associated with reduced risk of cancer: a meta-analysis.
Haque S; Akhter N; Lohani M; Ali A; Mandal RK
Asian Pac J Cancer Prev; 2015; 16(3):889-96. PubMed ID: 25735378
[TBL] [Abstract][Full Text] [Related]
38. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
39. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
40. FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects.
Xu L; Zhou X; Jiang F; Qiu MT; Zhang Z; Yin R; Xu L
PLoS One; 2013; 8(9):e74543. PubMed ID: 24086353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
